Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)

The organophosphate pesticide coumaphos is used to control Cattle Tick Fever carried by multiple species of ticks and is a known hazard for workers treating livestock. The USDA Cattle Fever Tick Eradication Program requires regular blood draws to measure depressed cholinesterase levels as biomarkers...

Full description

Saved in:
Bibliographic Details
Main Authors: Zachary G. Robbins, Cynthia A. Striley, Lee Wugofski
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:MethodsX
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2215016125000196
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591766425960448
author Zachary G. Robbins
Cynthia A. Striley
Lee Wugofski
author_facet Zachary G. Robbins
Cynthia A. Striley
Lee Wugofski
author_sort Zachary G. Robbins
collection DOAJ
description The organophosphate pesticide coumaphos is used to control Cattle Tick Fever carried by multiple species of ticks and is a known hazard for workers treating livestock. The USDA Cattle Fever Tick Eradication Program requires regular blood draws to measure depressed cholinesterase levels as biomarkers of effect of long-term coumaphos exposure, however, the gap between blood draws may miss intermittent high exposures. Urine biomonitoring can supplement blood draws, offering personnel a sensitive and cost-effective method to monitor short-term exposures. Our objective was to improve and validate a previously published method to analyze the coumaphos metabolite 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC). Urine samples were hydrolyzed with glucuronidase and then extracted prior to analysis with high-performance liquid chromatography-fluorescence detection. Calibration curves were linear over a wide CHMC range (0.49 – 250.07 ng/mL) with a method detection limit of 0.06 ng/mL. This research will help establish an accessible urine biomonitoring method for assessing coumaphos exposures. • The modified bioanalytical method maintained high sensitivity and specificity while reducing duration of the sample treatment steps and the chromatographic program. • Method validation tests followed the acceptance criteria guidelines in the NIOSH Manual of Analytical Methods. • CHMC levels were measured in workers exposed to coumaphos during livestock treatment.
format Article
id doaj-art-53049bcad4db4d979b56fcf61bf73631
institution Kabale University
issn 2215-0161
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series MethodsX
spelling doaj-art-53049bcad4db4d979b56fcf61bf736312025-01-22T05:42:33ZengElsevierMethodsX2215-01612025-06-0114103171Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)Zachary G. Robbins0Cynthia A. Striley1Lee Wugofski2Chemical and Biological Monitoring Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1090 Tusculum Ave, Cincinnati, OH 45226, USA; Corresponding author.Chemical and Biological Monitoring Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1090 Tusculum Ave, Cincinnati, OH 45226, USAFederal Occupational Health, Program Support Center, Assistant Secretary for Administration, Office of the Secretary, U.S. Department of Health and Human ServicesThe organophosphate pesticide coumaphos is used to control Cattle Tick Fever carried by multiple species of ticks and is a known hazard for workers treating livestock. The USDA Cattle Fever Tick Eradication Program requires regular blood draws to measure depressed cholinesterase levels as biomarkers of effect of long-term coumaphos exposure, however, the gap between blood draws may miss intermittent high exposures. Urine biomonitoring can supplement blood draws, offering personnel a sensitive and cost-effective method to monitor short-term exposures. Our objective was to improve and validate a previously published method to analyze the coumaphos metabolite 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC). Urine samples were hydrolyzed with glucuronidase and then extracted prior to analysis with high-performance liquid chromatography-fluorescence detection. Calibration curves were linear over a wide CHMC range (0.49 – 250.07 ng/mL) with a method detection limit of 0.06 ng/mL. This research will help establish an accessible urine biomonitoring method for assessing coumaphos exposures. • The modified bioanalytical method maintained high sensitivity and specificity while reducing duration of the sample treatment steps and the chromatographic program. • Method validation tests followed the acceptance criteria guidelines in the NIOSH Manual of Analytical Methods. • CHMC levels were measured in workers exposed to coumaphos during livestock treatment.http://www.sciencedirect.com/science/article/pii/S2215016125000196Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
spellingShingle Zachary G. Robbins
Cynthia A. Striley
Lee Wugofski
Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
MethodsX
Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title_full Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title_fullStr Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title_full_unstemmed Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title_short Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
title_sort quantification of 3 chloro 7 hydroxy 4 methylcoumarin chmc in urine as a biomarker of coumaphos exposure by high performance liquid chromatography fluorescence detection hplc fld
topic Quantification of 3‑chloro-7‑hydroxy-4-methylcoumarin (CHMC) in urine as a biomarker of coumaphos exposure by high-performance liquid chromatography-fluorescence detection (HPLC-FLD)
url http://www.sciencedirect.com/science/article/pii/S2215016125000196
work_keys_str_mv AT zacharygrobbins quantificationof3chloro7hydroxy4methylcoumarinchmcinurineasabiomarkerofcoumaphosexposurebyhighperformanceliquidchromatographyfluorescencedetectionhplcfld
AT cynthiaastriley quantificationof3chloro7hydroxy4methylcoumarinchmcinurineasabiomarkerofcoumaphosexposurebyhighperformanceliquidchromatographyfluorescencedetectionhplcfld
AT leewugofski quantificationof3chloro7hydroxy4methylcoumarinchmcinurineasabiomarkerofcoumaphosexposurebyhighperformanceliquidchromatographyfluorescencedetectionhplcfld